United States· US:55111-625_b5fb9efb-3369-e1f9-384c-bd22e8ecad92

Zafirlukast

A zafirlukast product containing zafirlukast, registered in United States by Dr. Reddys Laboratories Limited. The same ATC class is registered in 5 of our 19 countries.

ATC R03DC01US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedZafirlukastATCR03DC01REGISTER NO.US:55111-625_b5fb9efb…PACKS LISTED10CHECKEDSeptember 27, 2026

Where it is registered

Zafirlukast is registered in 5 of 19 countries.

Countries holding a registration under ATC R03DC01 (zafirlukast), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 4 of them publish a price we can compare per daily dose

Zafirlukast · ATC R03DC01

5 / 19 countries

  • Belgiumprice
  • Finlandprice
  • Norwayprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
ZAFIRLUKAST
Manufacturer
Dr. Reddys Laboratories Limited
Country
United States (US)
ATC code
R03DC01
ATC class
Zafirlukast
Defined daily dose
40 mg, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 10

  • ndc11
    5511162501
    100 TABLET, FILM COATED in 1 BOTTLE (55111-625-01)
  • ndc11
    5511162505
    500 TABLET, FILM COATED in 1 BOTTLE (55111-625-05)
  • ndc11
    5511162530
    30 TABLET, FILM COATED in 1 BOTTLE (55111-625-30)
  • ndc11
    5511162560
    60 TABLET, FILM COATED in 1 BOTTLE (55111-625-60)
  • ndc11
    5511162578
    10 BLISTER PACK in 1 CARTON (55111-625-78) / 10 TABLET, FILM COATED in 1 BLISTER PACK (55111-625-79)
  • ndc11
    55111-625-01
  • ndc11
    55111-625-05
  • ndc11
    55111-625-30
  • ndc11
    55111-625-60
  • ndc11
    55111-625-78

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

459 interactions on record for zafirlukast.

Graded by severity as the source publishes them — 15 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Zafirlukast · interactions on record

459 records

  • 15 severe
  • 265 moderate
  • 20 minor
  • 159 info

Most severe, free to view

  • LonafarnibA16AX20severe
  • MipomersenC10AX11severe
  • LomitapideC10AX12severe
  • PexidartinibL01EX15severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Zafirlukast in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All zafirlukast products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f7bf6b3b-0a0a-4133-b94c-2c358b132d91
GET /v1/drugs/f7bf6b3b-0a0a-4133-b94c-2c358b132d91?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "10",
  "substance": "ZAFIRLUKAST",
  "productndc": "55111-625",
  "dosage_form": "TABLET, FILM COATED",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA090372",
  "marketing_category": "ANDA"
}

See everything about zafirlukast.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.